| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0084 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.012 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |